Myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
AML relapsed again 5 months later and the patient was given chemotherapy.
2
However, there are conflicting results on the effects with other AML subtypes.
3
Results: Several biologic features of AML differ between older and younger individuals.
4
Patients and methods: We examined 178 adult patients with newly diagnosed AML.
5
In the UK, AML is governed by four Acts of primary legislation.
1
Specific rearrangements of chromosome 16 are well known in acutenonlymphocyticleukemia with abnormal eosinophils.
2
Low-dose Ara-C may provide an alternative therapy in the selected patient with acutenonlymphocyticleukemia or a myelodysplastic syndrome.
3
Twenty-seven patients over 60 years of age with acutenonlymphocyticleukemia (ANLL) were prospectively treated with one of three intensive chemotherapeutic regimens.
4
Chromosomal studies were performed in the same laboratory on 97 untreated cases of de novo acutenonlymphocyticleukemia M2.
5
In contrast, of 12 patients with either acutenonlymphocyticleukemia or acute lymphoblastic leukemia who underwent transplantation during relapse, 11 died within 6 months.
1
A 21-year-old man with an acutemyelocyticleukemia received a bone marrow graft from a cousin mismatched for a single HLA-DR locus antigen.
1
Photo taken in 2019, just before she was diagnosed with acutemyeloidleukaemia.
2
Background: There are little data from India on the management of acutemyeloidleukaemia.
3
An autopsy later found the girl had acutemyeloidleukaemia.
4
We report a cytogenetic subgroup of acutemyeloidleukaemia whose incidence is independent of age.
5
His focus then turned towards developing novel therapeutics for paediatric and adult acutemyeloidleukaemia.
1
A 64-yr-old female developed acutemyeloblasticleukemia following radiation and drug therapy for colon carcinoma.
1
Different subtypes of acutemyelogenousleukemia have distinct clinical presentations and courses.
2
Two patients developed acutemyelogenousleukemia after completion of 3 years of GM-CSF administration.
3
Immunotherapy trials for acutemyelogenousleukemia mainly have involved adults.
4
Especially BH-AC is the first choice agent for acutemyelogenousleukemia combined with other agents.
5
No acutemyelogenousleukemia or myelodysplastic syndrome was observed.
1
The results are presented of allogeneic transplantation for 363 patients with acute non-lymphoblastic leukemia treated in Seattle from May 1973 through December 1985.
1
The first patient was a 50 years woman with acutemyeloidleukemia.
2
Three cases of acutemyeloidleukemia were reported in the HEC arm.
3
They include oncology drugs for melanoma, prostate cancer and acutemyeloidleukemia.
4
Two cases of acutemyeloidleukemia were reported with the best available therapy.
5
Diseases with the poorest 6-mo prognosis were acutemyeloidleukemia and non-Hodgkin lymphoma.
Uso de anll em inglês
1
Complete remission was induced in about 80% of ANLL patients in both chemotherapies.
2
These findings underscore the heterogeneity of ANLL.
3
When the growth fraction was considered, however, ANLL proliferative activity was higher and more like that of normal BM.
4
HL-60 cells and ANLL cells were incubated with or without retinoids for 5 days.
5
As previously reported for ALL in infants, ANLL of infancy shows a similar heterogeneity regarding phenotypic and genotypic features.
6
At diagnosis of ANLL, all of the patients had a panmyelosis with variation in the predominant abnormal cell line.
7
The ANLL was commonly heralded by a brief preleukemic phase consisting of cytopenias and a variety of morphologic abnormalities.
8
We report on a patient with M4 - ANLL presenting with acute abdomen without any evidence of blood disorder.
9
Intensive therapy is indicated in the elderly patient 61 to 70 years of age with ANLL.
10
In contrast, evidence for B cell involvement was not detected in the patient whose ANLL progenitor cells exhibited restricted differentiative expression.
11
There were similar statistical significance for ANLL and ALL patients, P = 0.0271 and P = 0.0266 respectively.
12
Twenty-seven patients over 60 years of age with acute nonlymphocytic leukemia (ANLL) were prospectively treated with one of three intensive chemotherapeutic regimens.
13
Our study confirms the high incidence of myelomonocytic and monoblastic subtypes in infants with ANLL, which are particularly closely associated with chromosome 11 abnormalities.
14
These data show that MDR is very frequent in ANLL also at diagnosis and suggest that MDR can contribute to early failure of standard treatment.
15
Bacterial or fungal infections (considered life-threatening or fatal) occurred in 17 children with ALL and in 7 with ANLL.